Circulating microparticles and central blood pressure according to antihypertensive strategy

Clinics - Tập 74 - Trang e1234 - 2019
Nayara D. Massunaga1, Carolina N. França1,2, Henrique T. Bianco1, Carlos E.S. Ferreira1,3, Juliana T. Kato1, Rui M.S. Póvoa1, Antonio M. Figueiredo Neto4, Maria Cristina O. Izar1, Francisco Antonio Helfenstein Fonseca1
1Departamento de Medicina, Universidade Federal de Sao Paulo (UNIFESP), Sao Paulo, SP, BR
2Universidade Santo Amaro (UNISA), Sao Paulo, SP, BR
3Hospital Israelita Albert Einstein, Sao Paulo, SP, BR
4Instituto Nacional de Ciencia e Tecnologia de Fluidos Complexos, Universidade Sao Paulo, Sao Paulo, SP, BR

Tài liệu tham khảo

Khera, 2018, Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study, BMJ, 362, k2357, 10.1136/bmj.k2357 Chistiakov, 2015, Endothelial Barrier and Its Abnormalities in Cardiovascular Disease, Front Physiol, 6, 365, 10.3389/fphys.2015.00365 Belo, 2015, Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension, J Vasc Res, 52, 221, 10.1159/000441621 Barbaro, 2015, Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers, Blood Press, 24, 7, 10.3109/08037051.2014.940710 Brandão, 2010, Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control, Am J Hypertens, 23, 208, 10.1038/ajh.2009.214 Schiffrin, 2012, Vascular remodeling in hypertension: mechanisms and treatment, Hypertension, 59, 367, 10.1161/HYPERTENSIONAHA.111.187021 Sakamoto, 2012, Effects of candesartan in hypertensive patients with type 2 diabetes mellitus on inflammatory parameters and their relationship to pulse pressure, Cardiovasc Diabetol, 11, 118, 10.1186/1475-2840-11-118 Fonseca, 2015, Antihypertensive therapy increases natural immunity response in hypertensive patients, Life Sci, 143, 124, 10.1016/j.lfs.2015.10.030 Laurent, 2007, Recent advances in arterial stiffness and wave reflection in human hypertension, Hypertension, 49, 1202, 10.1161/HYPERTENSIONAHA.106.076166 Sarafidis, 2017, Ambulatory Pulse Wave Velocity Is a Stronger Predictor of Cardiovascular Events and All-Cause Mortality Than Office and Ambulatory Blood Pressure in Hemodialysis Patients, Hypertension, 70, 148, 10.1161/HYPERTENSIONAHA.117.09023 Omboni, 2017, Relationships between 24-h blood pressure variability and 24-h central arterial pressure, pulse wave velocity and augmentation index in hypertensive patients, Hypertens Res, 40, 385, 10.1038/hr.2016.156 Nomura, 2016, Microparticle and Atherothrombotic Diseases, J Atheroscler Thromb, 23, 1, 10.5551/jat.32326 França, 2012, Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease, Circ J, 76, 729, 10.1253/circj.CJ-11-1145 da Silva, 2011, Imbalance between endothelial progenitor cells and microparticles in HIV-infected patients naive for antiretroviral therapy, AIDS, 25, 1595, 10.1097/QAD.0b013e32834980f4 Pinheiro, 2012, Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease, Int J Cardiol, 158, 125, 10.1016/j.ijcard.2012.04.051 Jamerson, 2008, Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients, N Engl J Med, 359, 2417, 10.1056/NEJMoa0806182 Weber, 2016, Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy, J Clin Hypertens, 18, 299, 10.1111/jch.12816 Brook, 2018, Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients, J Am Heart Assoc, 7, 10.1161/JAHA.117.006940 Williams, 2006, Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study, Circulation, 113, 1213, 10.1161/CIRCULATIONAHA.105.595496 Williams, 2009, Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study, Circulation, 119, 53, 10.1161/CIRCULATIONAHA.108.785915 Lins, 2014, Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients, Cell Biochem Biophys, 70, 687, 10.1007/s12013-014-9973-9 Camargo, 2014, Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy, Braz J Med Biol Res, 47, 432, 10.1590/1414-431X20143628 Jardim, 2016, I RBH - First Brazilian Hypertension Registry, Arq Bras Cardiol, 107, 93 Anderson, 2010, Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis, Lab Invest, 90, 1549, 10.1038/labinvest.2010.152 Sansone, 2018, Release of endothelial microparticles in patients with arterial hypertension, hypertensive emergencies and catheter-related injury, Atherosclerosis, 273, 67, 10.1016/j.atherosclerosis.2018.04.012 Christersson, 2017, Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events, Thromb Haemost, 117, 1571, 10.1160/TH16-11-0837 Jalal, 2018, Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease, J Am Heart Assoc, 7, 10.1161/JAHA.117.007818 Nomura, 2009, Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus, Platelets, 20, 406, 10.1080/09537100903114545 Wang, 2011, Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner, Blood, 118, 2366, 10.1182/blood-2011-01-330878 Ridker, 2017, Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, N Engl J Med, 377, 1119, 10.1056/NEJMoa1707914 Ridker, 2006, Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial, Hypertension, 48, 73, 10.1161/01.HYP.0000226046.58883.32 Fonseca, 2003, Hydrochlorothiazide abolishes the anti-atherosclerotic effect of quinapril, Clin Exp Pharmacol Physiol, 30, 779, 10.1046/j.1440-1681.2003.03911.x Choi, 2018, Central and cerebral haemodynamic changes after antihypertensive therapy in ischaemic stroke patients: A double-blind randomised trial, Sci Rep, 8 Manisty, 2013, Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index, Br J Clin Pharmacol, 75, 79, 10.1111/j.1365-2125.2012.04342.x Fernandes, 2016, Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients, Cardiol Res, 7, 196, 10.14740/cr481w Yugar, 2018, Do thiazide diuretics reduce central systolic blood pressure in hypertension?, J Clin Hypertens, 20, 133, 10.1111/jch.13134 Lieber, 2011, Cardiovascular prevention: relationships between arterial aging and chronic drug treatment, J Hum Hypertens, 25, 524, 10.1038/jhh.2011.28 Chen, 2015, Effects of different types of antihypertensive agents on arterial stiffness: a systematic review and meta-analysis of randomized controlled trials, J Thorac Dis, 7, 2339 Weber, 2010, Cardiovascular events during differing hypertension therapies in patients with diabetes, J Am Coll Cardiol, 56, 77, 10.1016/j.jacc.2010.02.046